img

Global Vesicular Stomatitis (VS) Therapeutics Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Vesicular Stomatitis (VS) Therapeutics Market Insights, Forecast to 2034

Vesicular stomatitis is a zoonotic viral disease that primarily affects equines, cattle and swine. The virus can also infect sheep and goats as well as wildlife.
Market Analysis and InsightsGlobal Vesicular Stomatitis (VS) Therapeutics Market
Global Vesicular Stomatitis (VS) Therapeutics market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Vesicular Stomatitis (VS) Therapeutics industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Vesicular Stomatitis (VS) Therapeutics market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Vesicular Stomatitis (VS) Therapeutics market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Boehringer Ingelheim
Merck & Co
Zoetis
Vedco
Elanco
Ceva Santé Animale
Vibrac
Vetoquinol
IDEXX Laboratories
Covetrus
Neogen
Grand Pharmaceutical Group
Segment by Type
Symptomatic Medications
Vaccination

Segment by Application


Veterinary Hospitals
Veterinary Clinics
Retail Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Vesicular Stomatitis (VS) Therapeutics introduction, etc. Vesicular Stomatitis (VS) Therapeutics Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Vesicular Stomatitis (VS) Therapeutics
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vesicular Stomatitis (VS) Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Symptomatic Medications
1.2.3 Vaccination
1.3 Market by Application
1.3.1 Global Vesicular Stomatitis (VS) Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Veterinary Hospitals
1.3.3 Veterinary Clinics
1.3.4 Retail Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Vesicular Stomatitis (VS) Therapeutics Market Perspective (2018-2033)
2.2 Global Vesicular Stomatitis (VS) Therapeutics Growth Trends by Region
2.2.1 Vesicular Stomatitis (VS) Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Vesicular Stomatitis (VS) Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Vesicular Stomatitis (VS) Therapeutics Forecasted Market Size by Region (2024-2033)
2.3 Vesicular Stomatitis (VS) Therapeutics Market Dynamics
2.3.1 Vesicular Stomatitis (VS) Therapeutics Industry Trends
2.3.2 Vesicular Stomatitis (VS) Therapeutics Market Drivers
2.3.3 Vesicular Stomatitis (VS) Therapeutics Market Challenges
2.3.4 Vesicular Stomatitis (VS) Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Vesicular Stomatitis (VS) Therapeutics by Players
3.1.1 Global Vesicular Stomatitis (VS) Therapeutics Revenue by Players (2018-2023)
3.1.2 Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Vesicular Stomatitis (VS) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Vesicular Stomatitis (VS) Therapeutics, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Vesicular Stomatitis (VS) Therapeutics Market Concentration Ratio
3.4.1 Global Vesicular Stomatitis (VS) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vesicular Stomatitis (VS) Therapeutics Revenue in 2022
3.5 Global Key Players of Vesicular Stomatitis (VS) Therapeutics Head office and Area Served
3.6 Global Key Players of Vesicular Stomatitis (VS) Therapeutics, Product and Application
3.7 Global Key Players of Vesicular Stomatitis (VS) Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Vesicular Stomatitis (VS) Therapeutics Breakdown Data by Type
4.1 Global Vesicular Stomatitis (VS) Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Vesicular Stomatitis (VS) Therapeutics Forecasted Market Size by Type (2024-2033)
5 Vesicular Stomatitis (VS) Therapeutics Breakdown Data by Application
5.1 Global Vesicular Stomatitis (VS) Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Vesicular Stomatitis (VS) Therapeutics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Vesicular Stomatitis (VS) Therapeutics Market Size (2018-2033)
6.2 North America Vesicular Stomatitis (VS) Therapeutics Market Size by Type
6.2.1 North America Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2018-2023)
6.2.2 North America Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2024-2033)
6.2.3 North America Vesicular Stomatitis (VS) Therapeutics Market Share by Type (2018-2033)
6.3 North America Vesicular Stomatitis (VS) Therapeutics Market Size by Application
6.3.1 North America Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2018-2023)
6.3.2 North America Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2024-2033)
6.3.3 North America Vesicular Stomatitis (VS) Therapeutics Market Share by Application (2018-2033)
6.4 North America Vesicular Stomatitis (VS) Therapeutics Market Size by Country
6.4.1 North America Vesicular Stomatitis (VS) Therapeutics Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2018-2023)
6.4.3 North America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Vesicular Stomatitis (VS) Therapeutics Market Size (2018-2033)
7.2 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Type
7.2.1 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2018-2023)
7.2.2 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2024-2033)
7.2.3 Europe Vesicular Stomatitis (VS) Therapeutics Market Share by Type (2018-2033)
7.3 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Application
7.3.1 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2018-2023)
7.3.2 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2024-2033)
7.3.3 Europe Vesicular Stomatitis (VS) Therapeutics Market Share by Application (2018-2033)
7.4 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Country
7.4.1 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2018-2023)
7.4.3 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Vesicular Stomatitis (VS) Therapeutics Market Size (2018-2033)
8.2 China Vesicular Stomatitis (VS) Therapeutics Market Size by Type
8.2.1 China Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2018-2023)
8.2.2 China Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2024-2033)
8.2.3 China Vesicular Stomatitis (VS) Therapeutics Market Share by Type (2018-2033)
8.3 China Vesicular Stomatitis (VS) Therapeutics Market Size by Application
8.3.1 China Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2018-2023)
8.3.2 China Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2024-2033)
8.3.3 China Vesicular Stomatitis (VS) Therapeutics Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Vesicular Stomatitis (VS) Therapeutics Market Size (2018-2033)
9.2 Asia Vesicular Stomatitis (VS) Therapeutics Market Size by Type
9.2.1 Asia Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2018-2023)
9.2.2 Asia Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2024-2033)
9.2.3 Asia Vesicular Stomatitis (VS) Therapeutics Market Share by Type (2018-2033)
9.3 Asia Vesicular Stomatitis (VS) Therapeutics Market Size by Application
9.3.1 Asia Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2018-2023)
9.3.2 Asia Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2024-2033)
9.3.3 Asia Vesicular Stomatitis (VS) Therapeutics Market Share by Application (2018-2033)
9.4 Asia Vesicular Stomatitis (VS) Therapeutics Market Size by Region
9.4.1 Asia Vesicular Stomatitis (VS) Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2018-2023)
9.4.3 Asia Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Details
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Vesicular Stomatitis (VS) Therapeutics Introduction
11.1.4 Boehringer Ingelheim Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2018-2023)
11.1.5 Boehringer Ingelheim Recent Developments
11.2 Merck & Co
11.2.1 Merck & Co Company Details
11.2.2 Merck & Co Business Overview
11.2.3 Merck & Co Vesicular Stomatitis (VS) Therapeutics Introduction
11.2.4 Merck & Co Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2018-2023)
11.2.5 Merck & Co Recent Developments
11.3 Zoetis
11.3.1 Zoetis Company Details
11.3.2 Zoetis Business Overview
11.3.3 Zoetis Vesicular Stomatitis (VS) Therapeutics Introduction
11.3.4 Zoetis Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2018-2023)
11.3.5 Zoetis Recent Developments
11.4 Vedco
11.4.1 Vedco Company Details
11.4.2 Vedco Business Overview
11.4.3 Vedco Vesicular Stomatitis (VS) Therapeutics Introduction
11.4.4 Vedco Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2018-2023)
11.4.5 Vedco Recent Developments
11.5 Elanco
11.5.1 Elanco Company Details
11.5.2 Elanco Business Overview
11.5.3 Elanco Vesicular Stomatitis (VS) Therapeutics Introduction
11.5.4 Elanco Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2018-2023)
11.5.5 Elanco Recent Developments
11.6 Ceva Santé Animale
11.6.1 Ceva Santé Animale Company Details
11.6.2 Ceva Santé Animale Business Overview
11.6.3 Ceva Santé Animale Vesicular Stomatitis (VS) Therapeutics Introduction
11.6.4 Ceva Santé Animale Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2018-2023)
11.6.5 Ceva Santé Animale Recent Developments
11.7 Vibrac
11.7.1 Vibrac Company Details
11.7.2 Vibrac Business Overview
11.7.3 Vibrac Vesicular Stomatitis (VS) Therapeutics Introduction
11.7.4 Vibrac Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2018-2023)
11.7.5 Vibrac Recent Developments
11.8 Vetoquinol
11.8.1 Vetoquinol Company Details
11.8.2 Vetoquinol Business Overview
11.8.3 Vetoquinol Vesicular Stomatitis (VS) Therapeutics Introduction
11.8.4 Vetoquinol Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2018-2023)
11.8.5 Vetoquinol Recent Developments
11.9 IDEXX Laboratories
11.9.1 IDEXX Laboratories Company Details
11.9.2 IDEXX Laboratories Business Overview
11.9.3 IDEXX Laboratories Vesicular Stomatitis (VS) Therapeutics Introduction
11.9.4 IDEXX Laboratories Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2018-2023)
11.9.5 IDEXX Laboratories Recent Developments
11.10 Covetrus
11.10.1 Covetrus Company Details
11.10.2 Covetrus Business Overview
11.10.3 Covetrus Vesicular Stomatitis (VS) Therapeutics Introduction
11.10.4 Covetrus Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2018-2023)
11.10.5 Covetrus Recent Developments
11.11 Neogen
11.11.1 Neogen Company Details
11.11.2 Neogen Business Overview
11.11.3 Neogen Vesicular Stomatitis (VS) Therapeutics Introduction
11.11.4 Neogen Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2018-2023)
11.11.5 Neogen Recent Developments
11.12 Grand Pharmaceutical Group
11.12.1 Grand Pharmaceutical Group Company Details
11.12.2 Grand Pharmaceutical Group Business Overview
11.12.3 Grand Pharmaceutical Group Vesicular Stomatitis (VS) Therapeutics Introduction
11.12.4 Grand Pharmaceutical Group Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2018-2023)
11.12.5 Grand Pharmaceutical Group Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Vesicular Stomatitis (VS) Therapeutics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Symptomatic Medications
Table 3. Key Players of Vaccination
Table 4. Global Vesicular Stomatitis (VS) Therapeutics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global Vesicular Stomatitis (VS) Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Vesicular Stomatitis (VS) Therapeutics Market Share by Region (2018-2023)
Table 8. Global Vesicular Stomatitis (VS) Therapeutics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Vesicular Stomatitis (VS) Therapeutics Market Share by Region (2024-2033)
Table 10. Vesicular Stomatitis (VS) Therapeutics Market Trends
Table 11. Vesicular Stomatitis (VS) Therapeutics Market Drivers
Table 12. Vesicular Stomatitis (VS) Therapeutics Market Challenges
Table 13. Vesicular Stomatitis (VS) Therapeutics Market Restraints
Table 14. Global Vesicular Stomatitis (VS) Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Vesicular Stomatitis (VS) Therapeutics Revenue Share by Players (2018-2023)
Table 16. Global Top Vesicular Stomatitis (VS) Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vesicular Stomatitis (VS) Therapeutics as of 2022)
Table 17. Global Vesicular Stomatitis (VS) Therapeutics Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Vesicular Stomatitis (VS) Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Vesicular Stomatitis (VS) Therapeutics, Headquarters and Area Served
Table 20. Global Key Players of Vesicular Stomatitis (VS) Therapeutics, Product and Application
Table 21. Global Key Players of Vesicular Stomatitis (VS) Therapeutics, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share by Type (2018-2023)
Table 25. Global Vesicular Stomatitis (VS) Therapeutics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share by Type (2024-2033)
Table 27. Global Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Vesicular Stomatitis (VS) Therapeutics Revenue Share by Application (2018-2023)
Table 29. Global Vesicular Stomatitis (VS) Therapeutics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Vesicular Stomatitis (VS) Therapeutics Revenue Share by Application (2024-2033)
Table 31. North America Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America Vesicular Stomatitis (VS) Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe Vesicular Stomatitis (VS) Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 45. China Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 47. China Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Vesicular Stomatitis (VS) Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 63. Boehringer Ingelheim Company Details
Table 64. Boehringer Ingelheim Business Overview
Table 65. Boehringer Ingelheim Vesicular Stomatitis (VS) Therapeutics Product
Table 66. Boehringer Ingelheim Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2018-2023) & (US$ Million)
Table 67. Boehringer Ingelheim Recent Developments
Table 68. Merck & Co Company Details
Table 69. Merck & Co Business Overview
Table 70. Merck & Co Vesicular Stomatitis (VS) Therapeutics Product
Table 71. Merck & Co Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2018-2023) & (US$ Million)
Table 72. Merck & Co Recent Developments
Table 73. Zoetis Company Details
Table 74. Zoetis Business Overview
Table 75. Zoetis Vesicular Stomatitis (VS) Therapeutics Product
Table 76. Zoetis Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2018-2023) & (US$ Million)
Table 77. Zoetis Recent Developments
Table 78. Vedco Company Details
Table 79. Vedco Business Overview
Table 80. Vedco Vesicular Stomatitis (VS) Therapeutics Product
Table 81. Vedco Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2018-2023) & (US$ Million)
Table 82. Vedco Recent Developments
Table 83. Elanco Company Details
Table 84. Elanco Business Overview
Table 85. Elanco Vesicular Stomatitis (VS) Therapeutics Product
Table 86. Elanco Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2018-2023) & (US$ Million)
Table 87. Elanco Recent Developments
Table 88. Ceva Santé Animale Company Details
Table 89. Ceva Santé Animale Business Overview
Table 90. Ceva Santé Animale Vesicular Stomatitis (VS) Therapeutics Product
Table 91. Ceva Santé Animale Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2018-2023) & (US$ Million)
Table 92. Ceva Santé Animale Recent Developments
Table 93. Vibrac Company Details
Table 94. Vibrac Business Overview
Table 95. Vibrac Vesicular Stomatitis (VS) Therapeutics Product
Table 96. Vibrac Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2018-2023) & (US$ Million)
Table 97. Vibrac Recent Developments
Table 98. Vetoquinol Company Details
Table 99. Vetoquinol Business Overview
Table 100. Vetoquinol Vesicular Stomatitis (VS) Therapeutics Product
Table 101. Vetoquinol Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2018-2023) & (US$ Million)
Table 102. Vetoquinol Recent Developments
Table 103. IDEXX Laboratories Company Details
Table 104. IDEXX Laboratories Business Overview
Table 105. IDEXX Laboratories Vesicular Stomatitis (VS) Therapeutics Product
Table 106. IDEXX Laboratories Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2018-2023) & (US$ Million)
Table 107. IDEXX Laboratories Recent Developments
Table 108. Covetrus Company Details
Table 109. Covetrus Business Overview
Table 110. Covetrus Vesicular Stomatitis (VS) Therapeutics Product
Table 111. Covetrus Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2018-2023) & (US$ Million)
Table 112. Covetrus Recent Developments
Table 113. Neogen Company Details
Table 114. Neogen Business Overview
Table 115. Neogen Vesicular Stomatitis (VS) Therapeutics Product
Table 116. Neogen Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2018-2023) & (US$ Million)
Table 117. Neogen Recent Developments
Table 118. Grand Pharmaceutical Group Company Details
Table 119. Grand Pharmaceutical Group Business Overview
Table 120. Grand Pharmaceutical Group Vesicular Stomatitis (VS) Therapeutics Product
Table 121. Grand Pharmaceutical Group Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2018-2023) & (US$ Million)
Table 122. Grand Pharmaceutical Group Recent Developments
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Vesicular Stomatitis (VS) Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Vesicular Stomatitis (VS) Therapeutics Market Share by Type: 2022 VS 2033
Figure 3. Symptomatic Medications Features
Figure 4. Vaccination Features
Figure 5. Global Vesicular Stomatitis (VS) Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global Vesicular Stomatitis (VS) Therapeutics Market Share by Application: 2022 VS 2033
Figure 7. Veterinary Hospitals Case Studies
Figure 8. Veterinary Clinics Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Vesicular Stomatitis (VS) Therapeutics Report Years Considered
Figure 11. Global Vesicular Stomatitis (VS) Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Vesicular Stomatitis (VS) Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Vesicular Stomatitis (VS) Therapeutics Market Share by Region: 2022 VS 2033
Figure 14. Global Vesicular Stomatitis (VS) Therapeutics Market Share by Players in 2022
Figure 15. Global Top Vesicular Stomatitis (VS) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vesicular Stomatitis (VS) Therapeutics as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Vesicular Stomatitis (VS) Therapeutics Revenue in 2022
Figure 17. North America Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Vesicular Stomatitis (VS) Therapeutics Market Share by Type (2018-2033)
Figure 19. North America Vesicular Stomatitis (VS) Therapeutics Market Share by Application (2018-2033)
Figure 20. North America Vesicular Stomatitis (VS) Therapeutics Market Share by Country (2018-2033)
Figure 21. United States Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Vesicular Stomatitis (VS) Therapeutics Market Size YoY (2018-2033) & (US$ Million)
Figure 24. Europe Vesicular Stomatitis (VS) Therapeutics Market Share by Type (2018-2033)
Figure 25. Europe Vesicular Stomatitis (VS) Therapeutics Market Share by Application (2018-2033)
Figure 26. Europe Vesicular Stomatitis (VS) Therapeutics Market Share by Country (2018-2033)
Figure 27. Germany Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. China Vesicular Stomatitis (VS) Therapeutics Market Size YoY (2018-2033) & (US$ Million)
Figure 34. China Vesicular Stomatitis (VS) Therapeutics Market Share by Type (2018-2033)
Figure 35. China Vesicular Stomatitis (VS) Therapeutics Market Share by Application (2018-2033)
Figure 36. Asia Vesicular Stomatitis (VS) Therapeutics Market Size YoY (2018-2033) & (US$ Million)
Figure 37. Asia Vesicular Stomatitis (VS) Therapeutics Market Share by Type (2018-2033)
Figure 38. Asia Vesicular Stomatitis (VS) Therapeutics Market Share by Application (2018-2033)
Figure 39. Asia Vesicular Stomatitis (VS) Therapeutics Market Share by Region (2018-2033)
Figure 40. Japan Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. South Korea Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. China Taiwan Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Southeast Asia Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. India Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Australia Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Size YoY (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Share by Type (2018-2033)
Figure 48. Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Share by Application (2018-2033)
Figure 49. Middle East, Africa, and Latin America Vesicular Stomatitis (VS) Therapeutics Market Share by Country (2018-2033)
Figure 50. Brazil Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Mexico Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Turkey Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Israel Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. GCC Countries Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Boehringer Ingelheim Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2018-2023)
Figure 57. Merck & Co Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2018-2023)
Figure 58. Zoetis Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2018-2023)
Figure 59. Vedco Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2018-2023)
Figure 60. Elanco Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2018-2023)
Figure 61. Ceva Santé Animale Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2018-2023)
Figure 62. Vibrac Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2018-2023)
Figure 63. Vetoquinol Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2018-2023)
Figure 64. IDEXX Laboratories Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2018-2023)
Figure 65. Covetrus Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2018-2023)
Figure 66. Neogen Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2018-2023)
Figure 67. Grand Pharmaceutical Group Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2018-2023)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed